Skip to main content
Smart Investors Daily
IC

NASDAQ · ICUI

ICU Medical, Inc.

Healthcare · Medical - Instruments & Supplies

$175.76

Down-$2.72 (-1.52%)

Updated Nov 20, 2026, 2:01 AM

SID Score

6.0/10

Composite research score

Smart Money

58/100

Neutral

Market cap
3.63B
P/E ratio
-624.25
Dividend yield
0.00%
52-week range
$113.37 – $192.85
Volume
174.63K
Avg. volume
272.38K

Price performance · ICUI

ICUI price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

ICUI closed at $175.76 after 21 trading sessions, up 4.41% for the selected period.

Last close
$175.76
Period change
+4.41%
Period low
$161.83
Period high
$182.11
Daily close
View OHLC price history
ICUI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$178.285$178.285$173.2475$175.76174.63K
Nov 18, 2026$175.22$179.61$172.495$178.48214.95K
Nov 17, 2026$179.18$182.12$176.86$176.91289.39K
Nov 16, 2026$179.25$183.88$178.735$181.87366.98K
Nov 13, 2026$179.00$180.1899$177.515$179.27195.46K
Nov 12, 2026$179.20$179.95$176.80$177.30290.53K
Nov 11, 2026$180.26$182.22$173.105$178.26299.2K
Nov 10, 2026$177.61$183.03$176.86$182.11270.31K
Nov 9, 2026$173.90$181.285$172.55$178.85344.71K
Nov 6, 2026$165.00$174.82$164.375$172.11464.85K
Nov 5, 2026$173.99$177.45$164.30$167.65529.57K
Nov 4, 2026$167.01$175.325$166.21$172.62446.92K
Nov 3, 2026$163.00$166.475$160.39$161.83297.8K
Nov 2, 2026$166.66$167.325$161.41$162.38309.98K
Oct 30, 2026$169.64$170.00$163.145$163.78216.56K
Oct 29, 2026$168.85$169.65$166.1634$168.65202.5K
Oct 28, 2026$161.63$166.645$157.63$166.39156.45K
Oct 27, 2026$166.41$166.41$162.97$163.20323.15K
Oct 26, 2026$166.42$168.48$162.88$165.96155.39K
Oct 23, 2026$166.92$167.945$160.8859$166.62272.32K
Oct 22, 2026$160.98$168.62$160.67$168.33241.77K

Latest ICUI news

The latest Smart Investors Daily articles mentioning ICUI.

ICUI research

Overview

Company profile and research snapshot.

Company profile

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$163.00
Implied upside
—
Analysts
—
ICUI recent ratings
DateFirmRatingTarget
Nov 6, 2026KeybancOverweight—
Nov 6, 2026Piper SandlerOverweight—
Aug 7, 2026Piper SandlerOverweight—
Aug 7, 2026BTIGBuy—
Aug 7, 2026NeedhamBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 7, 2026

ICU Medical (ICUI) Climbed, But What Is Behind The Latest Attention?

ICU Medical (ICUI) is back in focus after third quarter results topped earnings and revenue expectations, driven by record Infusion Systems and Consumables sales and firmer adjusted profitability, with management reaffirming full year guidance near the upper end. Recent price action has picked up, with a 1-day share price return of 2.66%, a 7-day gain of 5.09%, and a 30-day rise of 10.31% taking ICU Medical to US$172.11. At the same time, a year-to-date share price return of 24.24% and a...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.